... pay Endoceutics $50 million of total upfront consideration and issue Endoceutics 600,000 unregistered shares of AMAG common stock. Further, AMAG will pay Endoceutics up to $10 million upon delivery of adequate launch quantities of …
Jones has also experienced a tough 2017 with his fund's position in AMAG Pharmaceuticals. The biotech's stock is down around 35% so far this year. AMAG's problems started in January when the company announced its fourth-quarter …
Jones has also experienced a tough 2017 with his fund's position in AMAG Pharmaceuticals. The biotech's stock is down around 35% so far this year. AMAG's problems started in January when the company announced its fourth-quarter …
One such stock that you may want to consider dropping is AMAG Pharmaceuticals, Inc. AMAG, which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current …
Revenue was reported as $532.1 million. AMAG Pharmaceuticals shares have declined 35 percent since the beginning of the year. The stock has climbed nearly 6 percent in the last 12 months. This story was generated by Automated …
Revenue was reported as $532.1 million. AMAG Pharmaceuticals shares have declined 35 percent since the beginning of the year. The stock has climbed nearly 6 percent in the last 12 months. This story was generated by Automated …